Clinical trial
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With…
NCT00003552 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Terminated
Key facts
| NCT number | NCT00003552 |
|---|---|
| Title | Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma |
| Official title | Phase I/II Study of HLA-Matched Peripheral Blood Mobilized Hematopoietic Progenitor Cell Transplantation Followed by Allogeneic T-cell Infusion as Adoptive Immunotherapy in Patients With Metastatic Melanoma |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Stage IV Melanoma, Recurrent Melanoma |
| Intervention type | Drug |
| Interventions | allogeneic lymphocytes, anti-thymocyte globulin, cyclophosphamide, fludarabine |
| Start date | Jan 1, 1999 |
| Completion | Oct 1, 2002 |
| First posted | Mar 5, 2007 |
| Last update posted | Mar 4, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: